216 related articles for article (PubMed ID: 14963352)
1. New cut-off point between T1 and T2 renal cell carcinoma - necessary for a better discriminatory power of the TNM classification.
Wunderlich H; Dreihaupt M; Schlichter A; Kosmehl H; Reichelt O; Schubert J
Urol Int; 2004; 72(2):123-8. PubMed ID: 14963352
[TBL] [Abstract][Full Text] [Related]
2. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.
Guðmundsson E; Hellborg H; Lundstam S; Erikson S; Ljungberg B;
Eur Urol; 2011 Nov; 60(5):975-82. PubMed ID: 21741160
[TBL] [Abstract][Full Text] [Related]
3. The histopathological heterogeneity of small renal cell carcinoma.
Wunderlich H; Schlichter A; Kosmehl H; Schubert J
Anticancer Res; 1999; 19(2C):1497-500. PubMed ID: 10365131
[TBL] [Abstract][Full Text] [Related]
4. Nephron sparing surgery for renal cell carcinoma 4 cm. or less in diameter: indicated or under treated?
Wunderlich H; Reichelt O; Schumann S; Schlichter A; Kosmehl H; Werner W; Vollandt R; Schubert J
J Urol; 1998 May; 159(5):1465-9. PubMed ID: 9554334
[TBL] [Abstract][Full Text] [Related]
5. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
[TBL] [Abstract][Full Text] [Related]
6. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.
Gilbert SM; Murphy AM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
Urology; 2006 Aug; 68(2):287-91. PubMed ID: 16904438
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma.
Steiner T; Knels R; Schubert J
Eur Urol; 2004 Sep; 46(3):327-30. PubMed ID: 15306102
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.
Kuczyk M; Wegener G; Jonas U
Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136
[TBL] [Abstract][Full Text] [Related]
9. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
10. Small renal tumors: correlation of clinical and pathological features with tumor size.
Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
[TBL] [Abstract][Full Text] [Related]
11. Prognostic stratification of localized renal cell carcinoma by tumor size.
Bedke J; Pritsch M; Buse S; Jakobi H; Elsaesser KH; Pahernik S; Haferkamp A; Hohenfellner M
J Urol; 2008 Jul; 180(1):62-7. PubMed ID: 18485376
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of lymph node dissection in renal cell carcinoma.
Matsuyama H; Hirata H; Korenaga Y; Wada T; Nagao K; Yamaguchi S; Yoshihiro S; Naito K
Scand J Urol Nephrol; 2005; 39(1):30-5. PubMed ID: 15764268
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
14. [Definition of early renal cell carcinoma--from the study of pathological and clinical findings according to tumor size].
Kitamura Y; Watanabe M; Komatubara S; Sakata Y
Hinyokika Kiyo; 1995 Jul; 41(7):511-5. PubMed ID: 7668180
[TBL] [Abstract][Full Text] [Related]
15. Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome.
Zisman A; Pantuck AJ; Chao D; Dorey F; Said JW; Gitlitz BJ; de Kernion JB; Figlin RA; Belldegrun AS
J Urol; 2001 Jul; 166(1):54-8. PubMed ID: 11435822
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma lung metastases surgery: pathologic findings and prognostic factors.
Assouad J; Petkova B; Berna P; Dujon A; Foucault C; Riquet M
Ann Thorac Surg; 2007 Oct; 84(4):1114-20. PubMed ID: 17888956
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
18. [Impact of tumor size on long-term survival of patients with organ-confined renal cell cancer].
Merseburger AS; Wegener G; Horstmann M; Oelke M; Zumbrägel A; Bokemeyer C; Kollmannsberger C; Jonas U; Stenzl A; Kuczyk M
Aktuelle Urol; 2003 Dec; 34(7):469-74. PubMed ID: 14655083
[TBL] [Abstract][Full Text] [Related]
19. Role of lymphadenectomy in renal cell carcinoma.
Ditonno P; Traficante A; Battaglia M; Grossi FS; Selvaggi FP
Prog Clin Biol Res; 1992; 378():169-74. PubMed ID: 1301578
[TBL] [Abstract][Full Text] [Related]
20. Influence of tumor stage, size, grade, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma.
Baltaci S; Orhan D; Soyupek S; Bedük Y; Tulunay O; Gögüs O
J Urol; 2000 Jul; 164(1):36-9. PubMed ID: 10840419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
